Middle East pharma market set to grow 15% annually

The pharmaceutical market in the Middle East is likely to grow by between 10% and 15% annually over the next three years, outstripping  more mature markets, forecasts a report from URCH Publishing.

Major Pharmaceutical Markets of the Middle East: An overview of Egypt,  Israel, Jordan, Lebanon, Saudi Arabia & UAE, says that massive growth  is being forecast for the pharmaceutical and biotechnology markets of  Middle Eastern states, driven by moves to liberalize national economies,  the introduction of mass health insurance and the determination of the  region's governments to become self-sufficient in drug production. All  these factors are leading to huge investments taking place in both the  private and public health sectors, with major benefits to the  pharmaceutical industry.